Can small animal imaging accelerate drug development?

Research output: Contribution to journalArticle

Abstract

Better mechanistic understanding of disease through mapping of the human and mouse genomes enables rethinking of human infirmity. In the case of cancer, for example, we may begin to associate disease states with their underlying genetic defects rather than with the organ system involved. That will enable more selective, nontoxic therapies in patients who are genetically predisposed to respond to them. Because one of the major goals of molecular imaging research is to interrogate gene expression noninvasively, it can impact greatly on that process. Most of molecular imaging research is undertaken in small animals, which provide a conduit between in vitro studies and human clinical imaging. We are fortunate to be able to manipulate small animals genetically, and to have increasingly better models of human disease. The ability to study those animals noninvasively and quantitatively with new, high-resolution imaging devices provides the most relevant milieu in which to find and examine new therapies.

Original languageEnglish (US)
Pages (from-to)211-220
Number of pages10
JournalJournal of Cellular Biochemistry
Issue numberSUPPL. 39
StatePublished - 2002

Fingerprint

Molecular imaging
Animals
Molecular Imaging
Imaging techniques
Pharmaceutical Preparations
Medical imaging
Human Genome
Research
Gene expression
Genes
Gene Expression
Equipment and Supplies
Defects
Therapeutics
Neoplasms
In Vitro Techniques
Clinical Studies

Keywords

  • Cell tracking
  • Drug development
  • Gene expression imaging
  • Molecular imaging
  • Small animal imaging

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

Can small animal imaging accelerate drug development? / Pomper, Martin Gilbert.

In: Journal of Cellular Biochemistry, No. SUPPL. 39, 2002, p. 211-220.

Research output: Contribution to journalArticle

@article{c3c0b3860759405ea77d39434a2b03cc,
title = "Can small animal imaging accelerate drug development?",
abstract = "Better mechanistic understanding of disease through mapping of the human and mouse genomes enables rethinking of human infirmity. In the case of cancer, for example, we may begin to associate disease states with their underlying genetic defects rather than with the organ system involved. That will enable more selective, nontoxic therapies in patients who are genetically predisposed to respond to them. Because one of the major goals of molecular imaging research is to interrogate gene expression noninvasively, it can impact greatly on that process. Most of molecular imaging research is undertaken in small animals, which provide a conduit between in vitro studies and human clinical imaging. We are fortunate to be able to manipulate small animals genetically, and to have increasingly better models of human disease. The ability to study those animals noninvasively and quantitatively with new, high-resolution imaging devices provides the most relevant milieu in which to find and examine new therapies.",
keywords = "Cell tracking, Drug development, Gene expression imaging, Molecular imaging, Small animal imaging",
author = "Pomper, {Martin Gilbert}",
year = "2002",
language = "English (US)",
pages = "211--220",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "SUPPL. 39",

}

TY - JOUR

T1 - Can small animal imaging accelerate drug development?

AU - Pomper, Martin Gilbert

PY - 2002

Y1 - 2002

N2 - Better mechanistic understanding of disease through mapping of the human and mouse genomes enables rethinking of human infirmity. In the case of cancer, for example, we may begin to associate disease states with their underlying genetic defects rather than with the organ system involved. That will enable more selective, nontoxic therapies in patients who are genetically predisposed to respond to them. Because one of the major goals of molecular imaging research is to interrogate gene expression noninvasively, it can impact greatly on that process. Most of molecular imaging research is undertaken in small animals, which provide a conduit between in vitro studies and human clinical imaging. We are fortunate to be able to manipulate small animals genetically, and to have increasingly better models of human disease. The ability to study those animals noninvasively and quantitatively with new, high-resolution imaging devices provides the most relevant milieu in which to find and examine new therapies.

AB - Better mechanistic understanding of disease through mapping of the human and mouse genomes enables rethinking of human infirmity. In the case of cancer, for example, we may begin to associate disease states with their underlying genetic defects rather than with the organ system involved. That will enable more selective, nontoxic therapies in patients who are genetically predisposed to respond to them. Because one of the major goals of molecular imaging research is to interrogate gene expression noninvasively, it can impact greatly on that process. Most of molecular imaging research is undertaken in small animals, which provide a conduit between in vitro studies and human clinical imaging. We are fortunate to be able to manipulate small animals genetically, and to have increasingly better models of human disease. The ability to study those animals noninvasively and quantitatively with new, high-resolution imaging devices provides the most relevant milieu in which to find and examine new therapies.

KW - Cell tracking

KW - Drug development

KW - Gene expression imaging

KW - Molecular imaging

KW - Small animal imaging

UR - http://www.scopus.com/inward/record.url?scp=0036984115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036984115&partnerID=8YFLogxK

M3 - Article

SP - 211

EP - 220

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - SUPPL. 39

ER -